» Articles » PMID: 2114434

Luteinizing Hormone Determinations Obtained with Either a Monoclonal and a Polyclonal Antibody Radioimmunoassay and Their Correlations with Clinical Findings

Overview
Publisher Springer
Specialty Endocrinology
Date 1990 Mar 1
PMID 2114434
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Detection of circulating levels of gonadotropin is fundamental in reproductive physiology and related disorders. The advent of monoclonal antibodies might supply the clinician with faster and more accurate estimates of these hormones. We have evaluated the hormonal determinations provided by a monoclonal assay and those generated from our previous assay, produced by the same manufacturer, based on polyclonal antibodies. Comparison was performed on blood samples collected from volunteers with regular menstruation (n = 51) or patients attending our Clinic. The correlation between data provided by the two assays fluctuated from the almost complete overlap of the physiological menstrual cycle to the striking dissociation of the patients (n = 13) receiving a Gonadotropin Hormone-Releasing Hormone analog for gonadotropin suppression. Intermediate coefficients of correlations were recorded in normal subjects undergoing a Gonadotropin Hormone-Releasing Hormone stimulation test (n = 12) and in patients with functional hypothalamic amenorrhea (n = 19) or polycystic ovarian disease (n = 37). Values obtained with the monoclonal assay tended to be lower than those recorded with the previous system. A closer correlation with the clinical findings was observed in the hormonal values originated with the monoclonal assay.

Citing Articles

Undetectable luteinizing hormone levels using a monoclonal immunometric assay.

Barbe F, Legagneur H, Watrin V, Klein M, Badonnel Y J Endocrinol Invest. 1995; 18(10):806-8.

PMID: 8787959 DOI: 10.1007/BF03349815.


Gonadotropin evaluation in the diagnosis of polycystic ovary syndrome using either a monoclonal or a polyclonal antibody radioimmunoassay.

Manieri C, Pastorino R, Marolda A, Musso M, Gellona A, Barberis A J Endocrinol Invest. 1992; 15(3):219-22.

PMID: 1624683 DOI: 10.1007/BF03348715.

References
1.
Franks S . Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf). 1989; 31(1):87-120. DOI: 10.1111/j.1365-2265.1989.tb00457.x. View

2.
Evans R, Doelle G, Lindner J, Bradley V, Rabin D . A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man. J Clin Invest. 1984; 73(1):262-6. PMC: 425009. DOI: 10.1172/JCI111200. View

3.
Beastall G, Ferguson K, OReilly D, Seth J, Sheridan B . Assays for follicle stimulating hormone and luteinising hormone: guidelines for the provision of a clinical biochemistry service. Ann Clin Biochem. 1987; 24 ( Pt 3):246-62. DOI: 10.1177/000456328702400303. View

4.
Dufau M, Catt K, Tsuruhara T . Retention of in vitro biological activities by desialylated human luteinizing hormone and chorionic gonadotropin. Biochem Biophys Res Commun. 1971; 44(5):1022-9. DOI: 10.1016/s0006-291x(71)80188-2. View

5.
Albertini A, Iacobello C, Pizzocolo G, Signorini C, Tosoni S, Pilo A . Suppliers of kits for lutropin, follitropin, and prolactin should all use the same calibrators. Clin Chem. 1984; 30(10):1723-4. View